NCT05512819

Simple Title
A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE GIVEN IN A SERIES OF 3 INFANT DOSES AND 1 TODDLER DOSE IN INFANTS IN INDIA AND TAIWAN

Pneumococcal Disease

Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition

Pneumococcal Disease

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.
Sex
Male or Female
The sex of people who may participate in a clinical trial (all, female, male). Sex is a person’s classification based on assignment at birth. Eligibility based on sex is distinct from eligibility based on gender.
Age
42 - 84 days
The age a person must be to participate in a clinical trial.
View more eligibility criteria on ClinicalTrials.gov

Study Locations

Study Locations
5 trials found.

National Taiwan University Hospital

Taipei, Taiwan, 100
Recruiting Get directions

Taichung Veterans General Hospital

Taichung, Taiwan, 407219
Recruiting Get directions

Mackay Memorial Hospital

Taipei, Taiwan, 10449
Recruiting Get directions

Chang Gung Medical Foundation-Linkou Branch

Taoyuan, Taiwan, 333
Recruiting Get directions

Mackay Memorial Hospital-Hsinchu

Hsinchu City, Hsinchu, Taiwan, 30071
Not yet recruiting Get directions